Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol

dc.contributor.authorDemirkan S.
dc.contributor.authorGündüz Ö.
dc.contributor.authorDevrim T.
dc.date.accessioned2020-06-25T15:17:50Z
dc.date.available2020-06-25T15:17:50Z
dc.date.issued2017
dc.departmentKırıkkale Üniversitesi
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1016/j.jdcr.2017.03.017
dc.identifier.endpage357en_US
dc.identifier.issn23525126
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85024862350
dc.identifier.scopusqualityQ3
dc.identifier.startpage354en_US
dc.identifier.urihttps://doi.org/10.1016/j.jdcr.2017.03.017
dc.identifier.urihttps://hdl.handle.net/20.500.12587/2546
dc.identifier.volume3en_US
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier Incen_US
dc.relation.ispartofJAAD Case Reports
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcalcipotriolen_US
dc.subjecthand-foot syndromeen_US
dc.subjecthepatitisen_US
dc.subjecthepatocellular carcinomaen_US
dc.subjectsorafeniben_US
dc.subjectsorafenib-associated hand-foot syndromeen_US
dc.subjecttreatmenten_US
dc.titleSorafenib-asssociated hand-foot syndrome treated with topical calcipotriolen_US
dc.typeArticle

Dosyalar